A new era in moderate- to- severe Atopic Dermatitis : Using Abrocitinb to get patients on the Right track
In this webinar, a detailed discussion is done on a new era in moderate- to- severe Atopic Dermatitis : Using Abrocitinb to get patients on the Right
Speakers : Dr. Sandipan Dhar ,Dr. Shireen Furtado ,Dr. Ramesh Bhat ,Dr. Debjit Kar ,Dr. Maitreyee Panda
New advances in the management of Atopic dermatitis & role of PDE4 Inhibitor
In this webinar, a detailed discussion is done through the interesting session on the new advances in the management of atopic dermatitis.
Speakers : Dr. Anup Kumar Lahiry ,Dr. Rajetha Damisetty ,Dr. Raghavendra Rao ,Dr. V Anand Kumar ,Dr. C Brijesh Nair
Recommended News For You
Recommended Articles For You
Featured News
Featured Articles
Featured Events
Featured KOL Videos
1.
Patients face high out-of-pocket costs after incident cancer diagnosis
2.
In a study, immune detection of oral cancers is linked to obesity.
3.
Researchers found that patients undergoing chemotherapy had a higher risk of mixed infections and should begin antibiotic therapy right away.
4.
Every cancer is different because of how evolution causes drug resistance and why various cancers require various treatments.
5.
Common intracellular toxin could help fight leukemia
1.
Understanding Sickle Cell Anemia: Causes, Symptoms, and Treatment Options
2.
The Latest Research on Chronic Granulomatous Disease and Promising New Treatments
3.
Advancing Oncology Careers with Education, Workflow Tools, and Clinical Resources
4.
Florinef: Understanding Its Uses and Side Effects
5.
Uncovering the Subtle Signs of Leukemia: A Guide to Early Detection
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases - Part II
2.
CDK4/6 Inhibitors Redefining Treatment for HR+/HER2- aBC In Post-Menopausal Women- A Panel Discussion
3.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
4.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VIII
5.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part II
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Welcome to Hidoc Dr.
Join to enhance your clinical skills and gain specialized in-depth medical knowledge